Filter
2211
Filtered Results: 2211
Text search:
specimen
Featured
Recommendations
302
New Publications
638
Language
Document type
No document type
1277
Guidelines
434
Studies & Reports
211
Manuals
107
Strategic & Response Plan
71
Fact sheets
54
Training Material
25
Situation Updates
18
Infographics
6
Videos
3
Online Courses
2
Brochures
1
Dashboards/Maps
1
Resource Platforms
1
Countries / Regions
India
146
South Africa
75
Nigeria
64
Kenya
61
Liberia
59
Sierra Leone
56
Western and Central Europe
50
Africa
44
Global
41
Ethiopia
41
Ghana
36
Tanzania
35
Zambia
35
Rwanda
34
Congo, Democratic Republic of
34
Uganda
31
Malawi
29
Nepal
25
Indonesia
24
West and Central Africa
23
Namibia
23
Zimbabwe
22
Philippines
22
Latin America and the Carribbean
22
Eastern Europe
21
Bangladesh
20
East and Southern Africa
19
Russia
18
Lesotho
17
Guinea
16
Myanmar / Burma
15
Germany
13
Syria
12
Cambodia
12
Mozambique
11
Haiti
11
Middle East and North Africa
11
Eastern Europe and Central Asia
11
Senegal
10
Burkina Faso
9
South–East Asia Region
9
Ukraine
8
Brazil
8
Botswana
8
Madagascar
8
Eswatini/ Swaziland
7
Tajikistan
6
Asia
6
Western Pacific Region
6
Spain
6
Mali
6
South Sudan
6
Pakistan
6
Benin
5
Cameroon
5
Peru
5
USA
5
Angola
5
Afghanistan
4
Italy
4
Côte d’Ivoire / Ivory Coast
4
Somalia
4
Colombia
3
Turkey
3
China
3
France
3
Argentina
3
Vietnam
3
Yemen
3
Palestine
3
Chad
3
Thailand
2
Gambia
2
Togo
2
Burundi
2
Qatar
2
Guinea-Bissau
2
Jordan
2
Saudi Arabia
2
Paraguay
2
Gabon
2
Southern Africa
2
Bolivia
2
Lebanon
2
Central African Republic
2
Libya
2
Iraq
2
North Macedonia
1
Timor Leste/ East Timor
1
El Salvador
1
Australia
1
Iran
1
Laos
1
Uzbekistan
1
Morocco
1
Mauritania
1
Venezuela
1
North America
1
Uruguay
1
Maldives
1
Mauritius
1
United Kingdom
1
Portugal
1
Moldova
1
Sri Lanka
1
Djibouti
1
Egypt
1
Sudan
1
Romania
1
Georgia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
932
Clinical Guidelines
264
Pharmacy & Technologies
87
Public Health
79
Key Resources
45
Women & Child Health
40
Capacity Building
23
Toolboxes
COVID-19
282
TB
263
Rapid Response
189
HIV
169
Ebola
122
AMR
113
NTDs
82
Pharmacy
36
Caregiver
35
Zika
35
Polio
29
Cholera
28
Mental Health
24
Planetary Health
22
Natural Hazards
18
Refugee
16
Conflict
12
Specific Hazards
10
NCDs
6
Health Financing Toolbox
4
Global Health Education
3
Disability
1
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var...
A WHO-UNICEF joint statement encouraging greater health commodity supply chain integration for temperature-sensitive pharmaceuticals where appropriate, 19 November 2020
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients with rifampicin-resistant and multi-drug resistant T...
Временные рекомендации27 мая 2021 г.
29 September 2021
Vaccination programmes against COVID-19 and seasonal influenza are currently being implemented in parallel in many countries. Administration of both vaccines during the same visit has potential advantages. This document presents the evidence related to coadministration of Covid-19 and influenza vacc...
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Despite the human and economic impact of viral epidemics, the world is not well enough prepared for the next emerging viral outbreak. Global trends indicate that new microbial threats will continue to emerge at an accelerating rate, driven by our growing population, expanded travel and trade network...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
On September 10, 2022, the Ministry of Health (MOH) announced a cholera outbreak in Aleppo governorate with 15 laboratory confirmed cases reported between August 25 and September 9, 2022. Activities under this plan seek to address the immediate needs stemming from this outbreak and highlight respons...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
At a glance. The COVID-19 pandemic revealed structural weaknesses in health systems worldwide and underscored the importance of building stronger, more integrated health systems to help prevent, prepare for, and respond to health crises. The critical moment that will determine countries’ resilienc...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
Schistosomiasis is an acute and chronic parasitic disease caused by blood flukes (trematode
worms) of the genus Schistosoma. At least 249 million people required preventive treatment in
2012. Preventive treatment, which should be repeated over a number of years, will reduce and
prevent morbidity.
Anopheles stephensi, a highly competent vector of Plasmodium falciparum and P. vivax, is considered an efficient vector of urban malaria. Until 2011, the reported distribution of An. stephensi was confined to certain countries of South Asia and parts of the Arabian Peninsula. Since then, the vector ...
